Search academic texts

Information × Registration Number 0204U006723, 0102U005866 , R & D reports Title Clinical trial to assess efficacy and safaty of glufosfamide as intravenous short time in fusion every three weeks in patients with breast cancer. popup.stage_title Head Stepula Vilen Vasilievich, Registration Date 20-12-2004 Organization Odessa state medical university popup.description2 Results of glufosfamide application in 6 patients with the advansed breast cancer are investigated. 4 patients have died within 6 months after the treatment. The number of the patients does not allow to draw authentic conclusions on efficiency of a preparation and a single doze of introduction. The further research of this preparation for today is impossible, as there were complexities by its manufacture, and company ASTA MEDICA has refused the further research in view of the bankruptcy Product Description popup.authors popup.nrat_date 2020-04-02 Close